Leukemic hypopyon in acute myeloid leukemia

被引:7
作者
Alten, Florian [1 ]
Ehlert, Karoline [2 ]
Boehm, Michael R. [1 ]
Grenzebach, Ulrike H. [1 ]
机构
[1] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany
[2] Univ Childrens Hosp Muenster, Dept Pediat Hematol & Oncol, Munster, Germany
关键词
Acute myeloid leukemia; Leukemic hypopyon; Masquerade syndrome;
D O I
10.5301/ejo.5000177
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Leukemic hypopyon uveitis in acute myeloid leukemia (AML) is a very rare condition. We report this case of an unusual finding in a 2(1/2)-year-old boy in second remission after chemotherapy for relapsed AML. METHODS. A young patient with an AML FAB M5 in second remission developed pain, photophobia, and conjunctival injections in the right eye. Recent bone marrow aspiration showed no blast increase and recent peripheral blood sampling presented no evidence of relapse. RESULTS. The patient showed a viscous hypopyon and a myotic pupil in the right eye that was refractory to corticosteroids. Anterior chamber aspiration revealed atypical blasts similar to the leukemic cells that were found in the bone marrow aspirate at the time of systemic relapse. CONCLUSIONS. Timely anterior chamber aspiration and subsequent cytology is useful in differentiating leukemic hypopyon from true intraocular inflammation in AML patients. This is the first report about a leukemic hypopyon uveitis in AML without systemic findings of malignant cells in a child.
引用
收藏
页码:252 / 254
页数:3
相关论文
共 50 条
  • [41] Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia
    Hoffmann, Marianne Hutchings
    Klausen, Tobias Wirenfeldt
    Boegsted, Martin
    Larsen, Steffen Falgreen
    Schmitz, Alexander
    Leinoe, Eva Birgitte
    Schmiegelow, Kjeld
    Hasle, Henrik
    Bergmann, Olav Jonas
    Sorensen, Suzette
    Nyegaard, Mette
    Dybkaer, Karen
    Johnsen, Hans Erik
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (03) : 123 - 131
  • [42] Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases
    Han, Lina
    Schuringa, Jan Jacob
    Mulder, Andre
    Vellenga, Edo
    ANNALS OF HEMATOLOGY, 2010, 89 (09) : 861 - 871
  • [43] An Auristatin nanoconjugate targeting CXCR4+leukemic cells blocks acute myeloid leukemia dissemination
    Pallares, Victor
    Unzueta, Ugutz
    Falgas, Aida
    Sanchez-Garcia, Laura
    Serna, Naroa
    Gallardo, Alberto
    Morris, Gordon A.
    Alba-Castellon, Lorena
    Alamo, Patricia
    Sierra, Jorge
    Villaverde, Antonio
    Vazquez, Esther
    Casanova, Isolda
    Mangues, Ramon
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [44] IGK with conserved IGKV/IGKJ repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration
    Wang, Chong
    Xia, Miaoran
    Sun, Xiaoping
    He, Zhiqiao
    Hu, Fanlei
    Chen, Lei
    Bueso-Ramos, Carlos E.
    Qiu, Xiaoyan
    Yin, C. Cameron
    ONCOTARGET, 2015, 6 (36) : 39062 - 39072
  • [45] Childhood Acute Myeloid Leukemia
    Jeffrey E. Rubnitz
    Current Treatment Options in Oncology, 2008, 9 : 95 - 105
  • [46] Angiogenesis in acute myeloid leukemia
    Testa, Ugo
    Castelli, Germana
    Pelosi, Elvira
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2020, 6
  • [47] Immunotherapy in Acute Myeloid Leukemia
    Grosso, Dolores A.
    Hess, Rosemary C.
    Weiss, Mark A.
    CANCER, 2015, 121 (16) : 2689 - 2704
  • [48] Pathobiology of acute myeloid leukemia
    Christ, Oliver
    Feuring-Buske, Michaela
    Hiddemann, Wolfgang
    Buske, Christian
    MEDIZINISCHE KLINIK, 2007, 102 (04) : 290 - 295
  • [49] Venetoclax in Acute Myeloid Leukemia
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
  • [50] Pharmacogenomics in acute myeloid leukemia
    Roumier, Christophe
    Cheok, Meyling H.
    PHARMACOGENOMICS, 2009, 10 (11) : 1839 - 1851